InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,160.78
(
0.24%
)
Post# of 3400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Aufklaerung

Send PM Follow Ignore
Followers 275
Posts 70785
Boards Moderated 6
Alias Born 11/21/2011

Aufklaerung

Re: None

Thursday, 05/21/2015 9:38:05 AM

Thursday, May 21, 2015 9:38:05 AM

Post# of 3400
$MYOS has recently announced the initiation of a clinical study on their Fortetropin® Dose Response. They're seeking to determine the effect of the supplementation on plasma myostatin levels, to help define the dose response curve. This study could be very beneficial for the company's long-term revenue and product growth. http://www.otcmarkets.com/stock/MYOS/news

“You're off to Great Places! Today is your day! Your mountain
is waiting, So... get on your way!” - Dr. Seuss

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up